Resistance Exercise for Type 1 Diabetes
Trial Summary
Will I have to stop taking my current medications?
The trial requires that participants do not take medications other than insulin that affect glucose metabolism, such as atypical antipsychotics or corticosteroids.
What data supports the effectiveness of this treatment for type 1 diabetes?
Research shows that resistance training, like weight lifting, can help people with type 1 diabetes manage their blood sugar levels better. Studies found that it can lower HbA1c (a measure of long-term blood sugar control) and improve overall health, making it a useful addition to treatment plans.12345
Is resistance exercise safe for people with type 1 diabetes?
How does resistance exercise differ from other treatments for type 1 diabetes?
Resistance exercise, like weight lifting, is unique for type 1 diabetes as it can improve muscle strength, body composition, and glycemic control (blood sugar levels) without the need for medication. Unlike aerobic exercise, it may offer additional benefits in reducing HbA1c (a measure of long-term blood sugar control) and enhancing insulin sensitivity.23489
What is the purpose of this trial?
Regular physical activity has substantial health benefits in people with type 1 diabetes. The fear of hypoglycemia, both during and after exercise, is a major barrier to exercise in this population. A major obstacle to providing specific physical activity and exercise advice is that there are still significant gaps in the fundamental understanding of the impact of physical activity and exercise on blood glucose levels in type 1 diabetes.Women with type 1 diabetes have a substantial increase in cardiovascular risk once they have passed menopause. They may lose both bone quality and muscle mass at a faster rate with aging than those without diabetes. Overall, these changes greatly increase the risk of both cardiovascular and frailty related complications. Despite the many potential benefits of resistance exercise for post-menopausal women with type 1 diabetes, there are currently no published studies examining the effects of resistance exercise in this population. Before being able to design a clinical trial of resistance exercise, an examination of the acute effects of resistance exercise on blood glucose levels in post-menopausal women with type 1 diabetes is required.The present study will compare the glycemic effects of a low resistance, high repetition (3 sets of 15 to 20 repetitions) weight lifting program to the effects of a moderate resistance, moderate repetition (3 sets of 8 to 10 repetitions). The investigators hypothesize that the high repetition program will be associated with a bigger decline in blood glucose during exercise, but that the moderate resistance program will be associated with a higher risk of post-exercise hypoglycemia.
Eligibility Criteria
This trial is for post-menopausal women with Type 1 Diabetes living near Edmonton, Alberta. They should have been diagnosed at least a year ago and not had a menstrual period in the last 12 months. Participants must be able to do resistance exercise but can't join if they have high blood pressure, cardiovascular disease history, are on certain medications, or have conditions affecting exercise ability.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-test Measures
Participants undergo pre-test measures including questions related to menopause, physical activity levels, medication, blood pressure, heart rate, anthropometric characteristics, and blood sample for HbA1c.
Testing Sessions
Participants perform resistance exercises in two sessions with different protocols, and blood samples are drawn at various times.
Follow-up
Participants are monitored for safety and effectiveness after exercise sessions, including CGM data collection and focus group participation.
Treatment Details
Interventions
- High repetition (HI)
- Moderate repetition (MOD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor